COSMOS: Further evidence for the benefits of guselkumab in PsA | Laura Coates - ViDoe

COSMOS: Further evidence for the benefits of guselkumab in PsA | Laura Coates

486 views

Medicine Matters rheumatology

3 years ago

COSMOS: Further evidence for the benefits of guselkumab in PsA | Laura Coates

COSMOS: Further evidence for the benefits of guselkumab in PsA | Laura Coates

COSMOS: Further evidence for the benefits of guselkumab in PsA | Laura Coates

6:03

COSMOS: Further evidence for the benefits of guselkumab in PsA | Laura Coates

by Medicine Matters rheumatology

Efficacy and Safety of Phase III Trial of Guselkumab in PsA: Drs. Yusof and Coates

6:03

Efficacy and Safety of Phase III Trial of Guselkumab in PsA: Drs. Yusof and Coates

Efficacy and safety of guselkumab in patients with active psoriatic arthritis

5:14

Efficacy and safety of guselkumab in patients with active psoriatic arthritis

by Annals of the Rheumatic Diseases

$PsA Podcast: Guselkumab \& Secukinumab – All the Latest in Efficacy \& Safety$

26:48

PsA Podcast: Guselkumab \& Secukinumab – All the Latest in Efficacy \& Safety

by The Immune-Mediated Inflammatory Disease Forum

(Part 2) 5 More Superfoods to Elevate Your Health! 🌟🥗

1:15

(Part 2) 5 More Superfoods to Elevate Your Health! 🌟🥗

by The Curiosity Chest

This Veggie Declared The Healthiest

4:26

This Veggie Declared The Healthiest

by Dr. Paul Haider

Psoriatic Arthritis - 3D Medical Animation

2:30

Psoriatic Arthritis - 3D Medical Animation

by Amerra Medical

Psoriatic Arthritis

8:58

Psoriatic Arthritis

by Zero To Finals

Cosentyx - Mechanism of Action in Plaque Psoriasis

3:12

Cosentyx - Mechanism of Action in Plaque Psoriasis

by Digimata Animation Studios

New Data on Janssen's TREMFYA For Psoriatic Arthritis Patients

10:08

New Data on Janssen's TREMFYA For Psoriatic Arthritis Patients

by HPR

$PsA Podcast: Herpes Zoster in JAK Inhibitor Therapies \& The APEX Protocol$

28:15

PsA Podcast: Herpes Zoster in JAK Inhibitor Therapies \& The APEX Protocol

by The Immune-Mediated Inflammatory Disease Forum

Janssen Reports Positive Phase 3 TREMFYA Data in Patients with Difficult-to-Treat PsA

9:57

Janssen Reports Positive Phase 3 TREMFYA Data in Patients with Difficult-to-Treat PsA

by HPR

The BE COMPLETE and BE OPTIMAL trials of bimekizumab in PsA | Joseph Merola

6:27

The BE COMPLETE and BE OPTIMAL trials of bimekizumab in PsA | Joseph Merola

by Medicine Matters rheumatology

SELECT-MONOTHERAPY Trial: Dr. Mike Putman

1:14

SELECT-MONOTHERAPY Trial: Dr. Mike Putman

In 2024 we're focusing on healthy, hydrated hair.

1:17

In 2024 we're focusing on healthy, hydrated hair.

further evidence

1:13

further evidence

by Atharva Rajput

Ixekizumab vs. guselkumab in plaque psoriasis, A. Blauvelt et al

4:08

Ixekizumab vs. guselkumab in plaque psoriasis, A. Blauvelt et al

by British Journal of Dermatology

Risankizumab shows promise for PsA in the KEEPsAKE 2 trial | Andrew Ostor

3:39

Risankizumab shows promise for PsA in the KEEPsAKE 2 trial | Andrew Ostor

by Medicine Matters rheumatology

$Discussing PsA: Clinical Response to Guselkumab \& Sequential Lines of b\/tsDMARDs$

32:11

Discussing PsA: Clinical Response to Guselkumab \& Sequential Lines of b\/tsDMARDs

by The Immune-Mediated Inflammatory Disease Forum

RNL 2021: Best of times, worst of times (Keynote): Dr. Iain McInnes

29:36

RNL 2021: Best of times, worst of times (Keynote): Dr. Iain McInnes

Amandha Vollmer | Pleomorphism

27:08

Amandha Vollmer | Pleomorphism